UPDATE: Citi Starts Amarin (AMRN) at Buy; Sees Favorable Risk/Reward Even if 'Going Alone' on Vascepa
- Japan's Nikkei posts biggest point gain for fiscal year
- Citi downgrades tech stocks as its flagship indicator signals 'euphoria' levels
- UBS sees 5 warnings signals on semiconductor chip stocks
- 2 reasons why Tesla stock fell on Thursday
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- AMC Entertainment (AMC) Enters $250M ATM Agreement
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Home Depot (HD) to Acquire SRS Distribution for $18.25B EV
Amarin Corp (AMRN) Receives U.S. Patent Covering Vascepa
November 27, 2012 7:31 AM ESTAmarin Corp Plc (NASDAQ: AMRN) that the U.S. Patent and Trademark Office (USPTO) has issued a patent covering Amarin's Vascepa® (icosapent ethyl) capsules based on U.S. Patent Application Serial No. 13/282,145. On September 4, 2012, Amarin announced the issuance of a Notice of Allowance for claims under this... More
Wedbush Comments on Amarin's (AMRN) Latest MARINE Family Notice of Allowance
November 26, 2012 1:04 PM ESTWedbush commented on Amarin Corporation (NASDAQ: AMRN) Monday afternoon in light of another Notice of Allowance to MARINE-family applications.
The firm notes today's '247 application is part of the MARINE methods-of-use family and claims the use of Vascepa without specifying use of other lipid lowering agents, such as statins. The '247 application appears to be closely related to the 775 application (13/608,775) for which Amarin announced... More
Amarin (AMRN) Announces Notification of Patent Allowance for U.S. Application
November 26, 2012 7:34 AM ESTAmarin Corporation plc (Nasdaq: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the United States Patent and Trademark Office (USPTO) has published notification of Notice of Allowance for U.S. Patent Application Serial Number 13/610,247. This application includes claims intended to protect the Vascepa® (icosapent ethyl) indication approved in July 2012 by the U.S. Food and Drug Administration (FDA) based on Amarin's MARINE clinical trial results.
The... More